Royal Bank of Canada
PTPI

Royal Bank of Canada’s Petros Pharmaceuticals PTPI Stock Holding History

Royal Bank of Canada’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– – – 7647
2022
Q1 		– Hold
0
– – – 7954
2021
Q4 		– Sell
-8
Closed -$4.69K – 7840
2021
Q3 		$4K Hold
8
– – ﹤0.01% 7205
2021
Q2 		$6K Hold
8
– – ﹤0.01% 7032
2021
Q1 		$7K Hold
8
– – ﹤0.01% 6950
2020
Q4 		$9K Buy
+8
New +$7.53K ﹤0.01% 6436

Other funds holding PTPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
V
Veritable Wilmington, Delaware $6.46B AUM 17.32% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Royal Bank of Canada's PTPI Position: Q2 2022 in Review

Royal Bank of Canada held its Petros Pharmaceuticals (PTPI) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7647.

Royal Bank of Canada first reported a position in PTPI in Q4 2020 and has held it in 4 quarters since. The position peaked at $9K in Q4 2020. 13 funds tracked by Wall St. Rank hold PTPI as of Q2 2022.

  • Royal Bank of Canada held 0 shares of Petros Pharmaceuticals worth $0 as of Q2 2022.
  • Royal Bank of Canada left its Petros Pharmaceuticals share count unchanged in Q2 2022.
  • Petros Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2022, its #7647 holding.
  • Royal Bank of Canada first reported a position in Petros Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • Royal Bank of Canada's Petros Pharmaceuticals position peaked at $9K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.